Information about C.E Pharma
My details
*
*
*

C.E Pharma (SRL)

BE

0793.409.817

Company information

Status
Active

Enterprise number

BE0793.409.817

VAT liability
Yes
Established
08-11-2022
Last balance sheet year
2025
Company size
Micro 1,1 FTE
Legal form
Société à responsabilité limitée (SRL)
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from C.E Pharma

2025 2024 2023
Income statement
Profit/Loss € -17,197 24% € -22,691 -39% € -16,279
Gross margin € 106,119 30% € 81,911 0% € 81,643
Balance sheet
Balance sheet total € 263,031 -22% € 336,365 -4% € 349,028
Equity € -46,167 -59% € -28,970 -361% € -6,279
Debts € 309,199 -15% € 365,335 3% € 355,307
Other
Employees 1.1 0.9 0.5

Publications from C.E Pharma

Date Publication
14-11-2022 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of C.E Pharma?
The VAT number of C.E Pharma is BE 0793.409.817.
Wat is the PEPPOL ID of C.E Pharma?
The PEPPOL ID of C.E Pharma is 0208:0793409817. Log in or start a free trial to see the full overview.
When was C.E Pharma founded?
C.E Pharma was founded on 08-11-2022.
What is the address of C.E Pharma?
The current registered office of C.E Pharma is located at Rue Ransfort 87, 1080 Molenbeek-Saint-Jean.
When was the last time C.E Pharma filed their annual financial statements?
The most recent financial statements of C.E Pharma were filed on 31-08-2026.
How many employees does C.E Pharma have?
There are 1,1 FTEs working at C.E Pharma according to the staff figures in the most recent financial statements.
What is the annual turnover of C.E Pharma?
At the time of its most recent financial statements, C.E Pharma did not publish any turnover figures. C.E Pharma reported a gross margin of €106,119.18.

Sources